Finpecia: Clinically Proven Hair Regrowth for Men
| Product dosage: 1mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 10 | $4.02 | $40.16 (0%) | 🛒 Add to cart |
| 20 | $2.51 | $80.32 $50.20 (38%) | 🛒 Add to cart |
| 30 | $2.01 | $120.48 $60.24 (50%) | 🛒 Add to cart |
| 60 | $1.17 | $240.96 $70.28 (71%) | 🛒 Add to cart |
| 90 | $1.00 | $361.45 $90.36 (75%) | 🛒 Add to cart |
| 120 | $0.84 | $481.93 $100.40 (79%) | 🛒 Add to cart |
| 180 | $0.61 | $722.89 $110.44 (85%) | 🛒 Add to cart |
| 270 | $0.56 | $1084.34 $150.60 (86%) | 🛒 Add to cart |
| 360 | $0.49
Best per pill | $1445.78 $175.70 (88%) | 🛒 Add to cart |
| Product dosage: 5mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 10 | $5.02 | $50.20 (0%) | 🛒 Add to cart |
| 20 | $3.01 | $100.40 $60.24 (40%) | 🛒 Add to cart |
| 30 | $2.34 | $150.60 $70.28 (53%) | 🛒 Add to cart |
| 60 | $1.34 | $301.20 $80.32 (73%) | 🛒 Add to cart |
| 90 | $1.12 | $451.81 $100.40 (78%) | 🛒 Add to cart |
| 120 | $0.92 | $602.41 $110.44 (82%) | 🛒 Add to cart |
| 180 | $0.78 | $903.61 $140.56 (84%) | 🛒 Add to cart |
| 270 | $0.74 | $1355.42 $200.80 (85%) | 🛒 Add to cart |
| 360 | $0.67
Best per pill | $1807.23 $240.96 (87%) | 🛒 Add to cart |
Finasteride, the active ingredient in Finpecia, is a well-established oral medication for the treatment of male pattern hair loss (androgenetic alopecia). It functions as a selective inhibitor of Type II 5-alpha-reductase, an enzyme responsible for converting testosterone into the more potent androgen, dihydrotestosterone (DHT). By significantly reducing serum and scalp DHT levels, Finpecia effectively halts the progression of hair loss and, in a majority of patients, stimulates the regrowth of miniaturized hairs. This guide provides a comprehensive, evidence-based overview for healthcare professionals and informed patients considering this therapeutic option.
Features
- Active Ingredient: Finasteride (1 mg)
- Pharmacological Class: 5-alpha-reductase inhibitor
- Presentation: Film-coated tablets
- Standard Dosage: One 1 mg tablet administered orally, once daily
- Mechanism of Action: Selective inhibition of the Type II isoenzyme of 5α-reductase
- Bioavailability: Approximately 63% (not affected by food)
- Protein Binding: ~90%
- Metabolism: Extensive hepatic metabolism primarily via CYP3A4
- Elimination Half-life: 6-8 hours in men aged 18-60
- Excretion: Approximately 39% in urine and 57% in feces as metabolites
Benefits
- Halts Hair Loss Progression: Clinically demonstrated to stop the progression of androgenetic alopecia in 83% of men after two years of treatment, compared to 28% on placebo.
- Stimulates Visible Regrowth: Promotes the reversal of the miniaturization process of hair follicles, leading to a statistically significant increase in hair count in the vertex (crown) and anterior mid-scalp areas.
- Long-Term Efficacy Maintained: Sustained improvement in hair growth has been observed in clinical studies continuing for up to five years, with no evidence of tachyphylaxis (reduced response over time).
- Convenient Dosing Regimen: A simple, once-daily oral dosage supports high levels of patient adherence and consistency, which is critical for therapeutic success.
- Well-Characterized Safety Profile: Over two decades of post-marketing surveillance and clinical use have provided a robust understanding of its tolerability and side effect profile.
- Non-Surgical Intervention: Provides a systemic, pharmacological alternative to surgical hair restoration procedures for suitable candidates.
Common use
Finpecia (finasteride 1 mg) is exclusively indicated for the treatment of male pattern hair loss (androgenetic alopecia) in men only. It is appropriate for use in men who present with mild to moderate hair loss in the vertex (crown of the head) and anterior mid-scalp areas. The medication is intended for chronic use; cessation of treatment leads to a gradual reversal of its beneficial effects, typically within 12 months, with hair loss returning to pretreatment levels. It is not indicated for use by women or children.
Dosage and direction
The recommended dosage is one 1 mg tablet taken orally once daily, with or without food. Adherence to a consistent daily schedule is paramount for optimal efficacy. The tablet should be swallowed whole with a glass of water; it should not be crushed or chewed. Clinical improvement is not immediate. A minimum period of three months of daily dosing is required before any initial assessment of response can be made, and at least six to twelve months of continuous therapy are typically needed to observe significant cosmetic improvement. Treatment can be continued as long as benefits are derived and the medication is well-tolerated.
Precautions
- Pregnancy Warning (Teratogenic Risk): Finasteride is contraindicated in women who are or may become pregnant due to the risk of abnormalities of the external genitalia in a male fetus. Tablets should not be handled by women who are pregnant or who may become pregnant. Crushed or broken tablets present a higher risk of exposure through skin contact.
- Prostate Cancer Screening: Finasteride reduces serum PSA levels by approximately 50% in men. Any interpretation of PSA values for prostate cancer screening in a patient taking Finpecia must be adjusted by doubling the reported PSA value to compare with normal ranges for untreated men. This should be discussed with a physician.
- Monitoring: While not routinely required for the 1 mg dose, periodic follow-up with a healthcare provider is recommended to assess therapeutic response and review any potential side effects.
- Underlying Conditions: Patients with liver dysfunction or severe urinary obstruction should use finasteride with caution and under close medical supervision, although the 1 mg dose has a wide margin of safety.
Contraindications
- Hypersensitivity to finasteride or any other component of the formulation.
- Use in women, particularly those who are pregnant or of childbearing potential.
- Use in pediatric patients.
Possible side effect
The majority of adverse reactions are sexual in nature and are reported in a small minority of patients. In placebo-controlled clinical trials for hair loss, the incidence of these events in the finasteride group was ≤3.8%, and they often decreased with continued therapy.
- Common (>1/100, <1/10): Erectile dysfunction, decreased libido (low sexual drive), ejaculation disorder (e.g., decreased ejaculate volume).
- Uncommon (>1/1000, <1/100): Breast tenderness and enlargement (gynecomastia).
- Rare: Allergic reactions including rash, itching, hives, and swelling of the lips and face.
- Post-Marketing Reports: Persistent sexual dysfunction (erectile dysfunction, diminished libido, ejaculatory disorders) that continued after discontinuation of the drug has been reported in a small number of men. The frequency of these events and their causal relationship to finasteride are not well-established. Depression and male breast cancer have also been reported very rarely; a causal relationship has not been established.
Drug interaction
Formal drug interaction studies have not been performed with the 1 mg dose. However, based on studies with the 5 mg dose, clinically important interactions are unlikely due to finasteride’s extensive metabolism. Theoretical interactions could occur with:
- Strong CYP3A4 Inhibitors (e.g., ketoconazole, itraconazole, ritonavir): May increase finasteride plasma concentrations. This is not expected to be clinically relevant for the 1 mg dose but should be considered.
- Other 5α-Reductase Inhibitors (e.g., dutasteride): Concomitant use is not recommended due to the potential for additive pharmacological effects without established benefit.
Missed dose
If a dose is missed, it should be skipped. The patient should not take a double dose to make up for the missed one. The next dose should be taken at the usual time the following day. Maintaining the regular daily schedule is more important than correcting for an occasional missed dose.
Overdose
In clinical trials, doses of finasteride up to 400 mg/day have been administered for three months without observed serious adverse effects. Single doses of up to 80 mg have been given without associated adverse events. In the event of a suspected overdose, symptomatic and supportive treatment is indicated. There is no specific antidote.
Storage
Store below 30°C (86°F). Keep the tablets in their original blister pack or container to protect them from light and moisture. Keep out of the reach of children and pets to prevent accidental ingestion.
Disclaimer
This information is for educational and informational purposes only and does not constitute medical advice. It is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition or before starting any new treatment. Never disregard professional medical advice or delay in seeking it because of something you have read here.
Reviews
- Clinical Study Data (NEJM, 1998): A landmark 2-year, double-blind, placebo-controlled study of 1,553 men demonstrated that 1 mg of finasteride daily increased hair count by 11% from baseline in the vertex scalp, compared to a 5% decrease in the placebo group. 83% of finasteride patients had no further hair loss vs. 28% on placebo. Physician global assessments showed improvement in 66% of men on finasteride vs. 7% on placebo.
- 5-Year Extension Study (J Am Acad Dermatol, 2002): A 5-year open-label extension of the original studies confirmed the long-term efficacy and safety of finasteride 1 mg. Hair count remained above baseline throughout the study period, indicating sustained prevention of progression and maintenance of regrowth.
- Patient Forums & Anecdotes: Across various patient communities, reviews are generally positive from men who have experienced stabilization of hair loss and noticeable regrowth. A common theme is the emphasis on patience, as results take many months to manifest. Discussions frequently center on managing expectations and the trade-off between efficacy and the potential for sexual side effects. Many users report no side effects, while a minority report issues that either resolve with time or lead to discontinuation.